NEW YORK (GenomeWeb) – Bruker reported after the close of the market Thursday that revenues in the third quarter grew 7 percent year over year.

For the three months ended Sept. 30 total revenues rose to $466.6 million from $435.6 million in Q3 2017, beating the consensus Wall Street estimate of $451.7 million.

The company saw a 1.5 percent positive effect from acquisitions and a 1.4 percent negative effect from currency effects on the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.